share_log

康希諾生物:股份發行人的證券變動月報表

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

香港交易所 ·  Mar 1 04:29
Summary by Moomoo AI
康希諾生物股份公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的公司股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在過去一個月內均無增減,H股和A股的結存數量分別維持在132,670,900股和114,778,999股。此外,根據2021年限制性股票激勵計劃,公司於2021年9月10日授出的限制性股票已於報告期內全部被收回,共計1,095,380股。公司亦確認,在2024年2月期間沒有進行A股的回購活動。康希諾生物的股份變動月報表為投資者提供了公司股本結構的最新情況。
康希諾生物股份公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的公司股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在過去一個月內均無增減,H股和A股的結存數量分別維持在132,670,900股和114,778,999股。此外,根據2021年限制性股票激勵計劃,公司於2021年9月10日授出的限制性股票已於報告期內全部被收回,共計1,095,380股。公司亦確認,在2024年2月期間沒有進行A股的回購活動。康希諾生物的股份變動月報表為投資者提供了公司股本結構的最新情況。
Consino Biological Corporation filed with Hong Kong Trading and Settlement Limited on 1 March 2024 with Hong Kong Trading and Settlement Limited on 1 March 2024, reporting the changes in the company's shares for the year ended 29 February 2024. The report showed that Conchino Bios's H shares (stock code 06185) and A shares (stock code 688185) were unchanged over the past month, and the number of H shares and A shares held at 132,670,900 shares and 114,778,999 shares, respectively. In addition, under the 2021 Restrictive Stock Incentive Program, the Company issued on September 10, 2021, has all been withdrawn during the reporting period for a total of 1,095,380 shares. The Company also confirmed that no repurchase of A shares took place during February 2024. CONCINO BIO'S MONTHLY STOCK CHANGE REPORT PROVIDES INVESTORS WITH AN UPDATE ON THE COMPANY'S SHARE CAPITAL STRUCTURE.
Consino Biological Corporation filed with Hong Kong Trading and Settlement Limited on 1 March 2024 with Hong Kong Trading and Settlement Limited on 1 March 2024, reporting the changes in the company's shares for the year ended 29 February 2024. The report showed that Conchino Bios's H shares (stock code 06185) and A shares (stock code 688185) were unchanged over the past month, and the number of H shares and A shares held at 132,670,900 shares and 114,778,999 shares, respectively. In addition, under the 2021 Restrictive Stock Incentive Program, the Company issued on September 10, 2021, has all been withdrawn during the reporting period for a total of 1,095,380 shares. The Company also confirmed that no repurchase of A shares took place during February 2024. CONCINO BIO'S MONTHLY STOCK CHANGE REPORT PROVIDES INVESTORS WITH AN UPDATE ON THE COMPANY'S SHARE CAPITAL STRUCTURE.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more